496849-46-8

Basic information

• Product Name: H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE)
• Synonyms: KE 108;H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE);TYR-(D-DAB4,ARG5,D-TRP8)-CYCLO-SOMATOSTATIN-14 (4-11);Tyr-(D-Dab,Arg,D-Trp)-cyclo-Somatostatin-14 (4-11)
• CAS NO: 496849-46-8
• Molecular Formula: C67H85N15O11
• Molecular Weight: 1276.49
• Mol File: 496849-46-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE)(CAS DataBase Reference)
• NIST Chemistry Reference: H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE)(496849-46-8)
• EPA Substance Registry System: H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE)(496849-46-8)

Safety Data

• Hazardous Substances Data: 496849-46-8(Hazardous Substances Data)

Usage

Description

H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE) is a cyclic peptide composed of a specific sequence of amino acids, including tyrosine, cyclo(D-DAB-arginine-phenylalanine-phenylalanine-D-tryptophan-lysine-threonine-phenylalanine). The cyclic structure formed by D-DAB, ARG, PHE, PHE, D-TRP, and LYS amino acids contributes to its stability and potential bioactivity. The unique sequence of amino acids in this peptide may be significant for its potential pharmacological or biological activities, making it a promising candidate for research and development in pharmaceuticals and biochemistry.

Uses

Used in Pharmaceutical Industry:
H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE) is used as a potential therapeutic agent for various applications due to its unique cyclic structure and specific sequence of amino acids. The stability and potential bioactivity of this peptide make it a subject of interest for further research and exploration in the development of new drugs and therapies.
Used in Biochemical Research:
H-TYR-CYCLO(-D-DAB-ARG-PHE-PHE-D-TRP-LYS-THR-PHE) is used as a research tool in biochemistry to study the structure, function, and interactions of cyclic peptides. The specific sequence of amino acids in this peptide may provide insights into the design and development of novel bioactive molecules with potential applications in various fields.

Relevant articles and documents

A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors.

All commercially available somatostatin analogs for clinical use have a preference for some but not all somatostatin receptor subtypes. We describe here the synthesis and evaluation in binding and cAMP assays with cell lines stably transfected with sst(1)